Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Impax CNS Franchise Starts With Carbatrol Promotion; Vadova Pending

This article was originally published in The Pink Sheet Daily

You may also be interested in...



Vadova Launch Uncertain Following “Not Approvable” Letter From FDA

Impax seeks a meeting with the agency after a negative review that included inspection of a contract laboratory.

Vadova Launch Uncertain Following “Not Approvable” Letter From FDA

Impax seeks a meeting with the agency after a negative review that included inspection of a contract laboratory.

Shire Settles Adderall XR Patent Case With Impax, But Remains At Impasse With Barr

If a generic amphetamine extended-release launches before 2010, Impax will sell Shire’s authorized generic.

Topics

UsernamePublicRestriction

Register

LL016789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel